Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IMGN > SEC Filings for IMGN > Form 8-K on 5-Nov-2013All Recent SEC Filings

Show all filings for IMMUNOGEN INC

Form 8-K for IMMUNOGEN INC


5-Nov-2013

Other Events, Financial Statements and Exhibits


ITEM 8.01 - OTHER EVENTS

On November 5, 2013, ImmunoGen, Inc. (the "Company") announced its decision to stop the Phase II trial evaluating its IMGN901 product candidate as part of a combination regimen for the treatment of small-cell lung cancer. Additional information is contained in the Company's press release dated November 5, 2013, which is incorporated herein by reference.



ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d): The following exhibit is being furnished herewith:

Exhibit No. Exhibit

99.1 Press Release of ImmunoGen, Inc. dated November 5, 2013

  Add IMGN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IMGN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.